Back to Rankings

AMRX

AmnealA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
AMRX vs peer average
95/100
AMRX vs. peer average (A vs. D)
Grade spread
C 2 · D 8
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Large-cap biopharma benchmark with substantially greater scale; limited operating comparability to Amneal’s generics, specialty, and biosimilar mix.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
AMRX
Amneal
AMGN
Amgen
Grade
A
D
Momentum
83
37
Value
64
63
Sentiment
47
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs AMGN

AMRX / AMGN
Grade Position
Above peers
AMRX vs. peer average (A vs. D)
95/100
Momentum
83
AMRX
Value
64
AMRX
Sentiment
47
AMRX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AMRX
1
AMGN
AMGN
D
40/100
+3
2
GILD
GILD
C
60/100
+2
3
DNTH
DNTH
D
40/100
+3
4
ORKA
Oruka Therapeutics Inc Common
D
40/100
+3
5
TWST
Twist Bioscience Corp Common
D
40/100
+3
AMGN is the first peer returned for this comparison set.